Positive vs. Negative Controls: What Each Checks

What is the difference between positive and negative controls?

In a laboratory assay, a positive control has an expected detectable response; a negative control has an expected absence of the target response or a defined baseline. Together, they help researchers check particular aspects of a measurement. Their meaning depends on the method and comparison. They do not prove every conclusion in a study or interpret a personal test result; clinical questions belong with the responsible clinician.

An assay is a procedure used to measure or detect something. When reading its results, ask what each control was intended to establish before deciding what the unknown samples mean.

What question does each control answer?

The RIPOSTE research-design framework distinguishes analytical controls, which check laboratory processes, from comparison groups used to answer a study's research question. A known reference sample and a group receiving an established treatment can both be called a positive control, while performing different jobs.

Write the role beside the label. “Compared with the control” is incomplete if the reader cannot identify which control the sentence means.

Does negative mean zero, and positive mean a high number?

Not necessarily. In the Assay Guidance Manual's in vivo chapter, a negative control provides a minimally effective comparison, while a positive control can establish a maximally effective reference response. These are roles within the specified assay, not universal numerical values.

The same chapter cautions that controls at the extremes may not describe measurement variability in the middle of the assay's range. Passing two endpoints therefore does not establish equally good performance everywhere between them.

Read the measured outcome and its direction. “Positive control” is not a promise that every graph will show its tallest bar in that group. The method must explain what response was expected.

Is a no-template control the same as a negative sample?

The distinction is particularly clear in quantitative polymerase chain reaction, or qPCR. The MIQE 2.0 reporting guidelines describe positive controls containing the target sequence, negative controls lacking that sequence but containing background nucleic acid, and no-template controls lacking sample nucleic acid. These check different possibilities.

A no-template control helps reveal contamination or artifacts; it does not represent every property of a sample containing other biological material. Read the authors' exact control description. Do not infer a result's validity from the abbreviation alone or transfer a decision rule from another assay.

Can a control check one problem while missing another?

Yes. Immunohistochemistry uses antibodies to help locate target molecules in tissue. The Histochemical Society's standards describe positive controls with a known target in its expected location. An internal control is within the specimen; an external control is a separate specimen.

The standards also identify a frequent overclaim: omitting the primary antibody can check nonspecific binding of the secondary antibody, but does not establish that the primary antibody specifically recognizes the intended target. “No staining in the control” needs its full experimental context.

This is a useful reading habit beyond that example: name the alternative explanation being checked. A control should receive credit for the question it addresses, without silently being promoted into proof against every possible error.

What happens when a control behaves unexpectedly?

Look for the method's acceptance rules and the authors' account of what happened. Do not erase an inconvenient control result or decide independently that the unknown samples remain interpretable.

For a concrete, bounded example, FDA's immunohistochemistry guidance describes invalid specimen results when the positive tissue control fails to stain, or when specific staining appears in the negative external tissue control. It assigns clinical interpretation to a qualified pathologist. These are statements about that method, not a universal rule for every experiment.

Researchers should follow their validated method and laboratory quality procedures. Readers should record an unresolved limitation rather than inventing a correction.

How can you keep the interpretation precise?

Try this fictional reading note, which describes no real experiment:

“The report names a positive reference and a negative reference. It states their expected behavior but does not show their observed results. I can identify the intended checks, but cannot establish from this report whether those checks passed.”

That note distinguishes a missing report from a demonstrated failure. It also avoids treating the presence of a control's name as evidence of its performance.

Use a short reading card:

• What material or condition served as the control?
• Which part of the procedure did it check?
• What result was expected, and what was observed?
• Were the acceptance rules stated?
• Which conclusion depends on that check?

Keep related questions separate. Replicates concern what was repeated; in vitro and in vivo identify experimental settings. Neither label supplies the missing control information. Our research methods collection helps connect those descriptions while keeping their limits visible.

Sources

• RIPOSTE: laboratory research design and analytical controls
• Assay Guidance Manual: In Vivo Assay Guidelines
• MIQE 2.0: qPCR reporting guidelines
• Histochemical Society: controls for immunohistochemistry
• FDA: immunohistochemistry application guidance